The Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) is a collaboration of multi-disciplinary HIV researchers from UCLA, Charles Drew University of Medicine and Science, Friends Research Institute, and the RAND Corporation. Funded by the National Institutes of Mental Health, CHIPTS promotes collaborative research, fosters networking, and supports capacity building among communities and agency partners in efforts to eliminate new HIV infections and improve health outcomes for key populations with HIV-associated comorbidities.
Featured News
Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo (lenacapavir)—the company’s injectable HIV-1 […]
This notice updates the Effective Date of the 2024 NIH Public Access Policy, NOT-OD-25-047, to July 1, 2025 at which time it will replace the 2008 Public Access Policy. All other aspects of the Policy remain the same. […]
On May 19, 2025 – CHIPTS will join partners across the U.S. in observing National Asian & Pacific Islander HIV/AIDS Awareness Day, a day to raise awareness and promote action against HIV and AIDS within Asian and Pacific […]
NIH continues to adjust its grants and funding processes in response to shifting agency priorities and federal guidance. Key updates include changes to application requirements – such as revised review criteria and procedures for […]
Recent Publications
Upcoming Events
Learning Opportunities
UCLA HIV Grand Rounds 2024-25
The Grand Rounds are monthly lecture series, which is offered by the UCLA CHIPTS, UCLA-CDU CFAR, & UCLA AIDS Institute and delivered by invited guests or distinguished members of the Institute faculty on a broad range of HIV-related topics. […]
Publication Management
UCLA CHIPTS provides resources for manuscript development, publication compliance, and publication management. Making research results publicly accessible is important not only to the NIH, but also to UCLA’s commitment to academic freedom and mission to disseminate knowledge […]